Executive Summary
Mega contracts totaling $10.8B highlight concentrated bullish signals in VA medical disability exams ($3.3B across Leidos' QTC and VES subsidiaries for FY26), DOE environmental remediation ($3.9B to AECOM's UCOR), and lab operations ($2.0B to FERMI nonprofit), signaling robust federal healthcare and cleanup spending. Firm fixed price structures dominate (15/17 contracts), offering revenue visibility but exposing contractors to cost overrun risks, with $0 outlayed on all new FY26 VA awards ($3.3B) pending execution. Unobligated options exceed $1B across deals, providing upside amid multi-year DOE/DHS commitments through 2028.
Tracking the trend? Catch up on the prior Mega Contracts Monitor ($100M+) digest from December 27, 2025.
Investment Signals(5)
- Leidos QTC dominates VA FY26 medical exams with $1.77B(HIGH)▲
Four firm fixed price delivery orders totaling $1.77B for 2026 disability exams via full/open competition signal entrenched positioning in growing VA healthcare.
- VES secures $1.52B in parallel VA FY26 awards(HIGH)▲
Four $100M+ delivery orders totaling $1.52B for identical medical exams reinforce competitive strength in NAICS 621111 services.
- AECOM's UCOR lands $3.9B DOE Oak Ridge cleanup(HIGH)▲
$839M already outlayed on $4.2B potential contract underscores multi-year revenue from environmental remediation despite passed end dates.
- DHS prioritizes border/shipbuilding with $755M(MEDIUM)▲
RAUMA's $521M Arctic Cutters and Barnard's $235M border infrastructure signal sustained homeland security capex through 2028.
- FERMI nonprofit secures $2.0B DOE lab ops to 2029(HIGH)▲
$595M outlayed on stable cost-plus funding for FNAL operations provides no direct equity upside but affirms DOE R&D commitment.
Risk Flags(3)
- Execution[HIGH RISK]▼
$0 outlayed on $3.3B FY26 VA awards despite full obligations risks funding delays or non-execution in 2026.
- Market[HIGH RISK]▼
Firm fixed price on 15/17 contracts ($9.5B+) exposes to cost overruns in medical, construction, and shipbuilding amid inflation.
- Execution[MEDIUM RISK]▼
Long-duration contracts (UCOR to 2022, FERMI/ENERGIA to 2028/2029) face DOE budget cuts or extensions uncertainty.
Opportunities(3)
- ◆
$1B+ in unexercised options (e.g., RAUMA $602M, CACI $93M, UCOR $281M) across 7 contracts offer scalable revenue.
- ◆
VA FY26 medical exam focus ($3.3B) positions winners for FY27 follow-ons amid veterans healthcare expansion.
- ◆
Progressed contracts with high outlays (UCOR $839M, FERMI $595M, Chartwell $99M) provide derisked cash flow through 2025-2028.
Sector Themes(3)
- ◆
10/17 contracts ($3.3B, 31% of total) cluster in FY26 medical screenings for Leidos/VES, all firm fixed price with San Antonio performance.
- ◆
$5.9B (54% of total) in legacy/multi-year DOE awards to UCOR/FERMI affirm environmental cleanup and lab ops funding.
- ◆
$755M in non-competed/competitive border/ship contracts signal capex despite foreign (RAUMA) winners.
Watch List(3)
- 👁
{"entity"=>"Leidos Holdings (QTC)", "reason"=>"$1.77B FY26 VA cluster represents 16% of period total, testing execution on $0 outlayed awards.", "trigger"=>"Q1 2026 outlays >$200M or margin erosion"}
- 👁
{"entity"=>"AECOM (UCOR)", "reason"=>"Largest single award ($3.9B, 36% of total) with passed end date and $281M options.", "trigger"=>"extension to 2022 or new DOE cleanup bids"}
- 👁
{"entity"=>"VA FY27 Medical Exam Solicitations", "reason"=>"Precedent of $3.3B FY26 awards to Leidos/VES could repeat, signaling sector growth.", "trigger"=>"RFP releases in H1 2026"}
Get daily alerts with 5 investment signals, 3 risk alerts, 3 opportunities and full AI analysis of all 17 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC